The FDA label for Increlex explicitly warns of hypoglycaemia, intracranial hypertension, and slipped capital femoral epiphysis as serious adverse events
Because of semaglutide and tirzepatide shortages, which have forced patients to involuntarily stop and restart treatment, reliable data on adherence for GLP-1s is not yet available
Here are the main ones: For Weight Loss: Wegovy (semaglutide) Zepbound (tirzepatide) Saxenda (liraglutide) For Diabetes (sometimes used for weight loss): Ozempic (semaglutide) Mounjaro (tirzepatide) Trulicity (dulaglutide) Victoza (liraglutide) Rybelsus (oral semaglutide) Most GLP-1 medications come as shots you give yourself once a week
The peptide may even have the potential to salvage damaged or avulsed dental material
They have extremely powerful feet and long, very sharp talons
They are not intended for human or animal consumption, clinical use, or veterinary applications, and are not intended to diagnose, treat, cure, or prevent any disease